
Bio Break: Groundbreaking Discoveries in Infectious Disease
In this episode of Bio Break, Nick shares one of his favorite discoveries in the world of infectious disease research — the groundbreaking discovery of Helicobacter pylori and its role in causing peptic ulcers. This fascinating story showcases how persistence, scientific curiosity, and innovative thinking can lead to discoveries that reshape medical science.
The discovery of Helicobacter pylori dates back to the 1980s, when Australian physicians Barry Marshall and Robin Warren suspected that stomach ulcers were not caused by stress or spicy foods, as commonly believed, but by a bacterium. Through determination and clever research, they identified Helicobacter pylori — a gram-negative, spiral-shaped bacterium — as the culprit. Their discovery wasn’t without challenges. Early laboratory cultures of patient swabs yielded no growth, as H. pylori requires low-oxygen environments and longer incubation periods to grow. It was only after a fortunate weekend delay that colonies finally appeared, changing the course of the study.
Nick recounts how, to prove their theory, Barry Marshall famously ingested a pure culture of H. pylori. This led to him developing gastritis and an ulcer, definitively proving the bacteria’s role. Thankfully, he treated the infection with antibiotics, validating the hypothesis and demonstrating that ulcers could be cured through antimicrobial therapy rather than solely through lifestyle changes.
This discovery revolutionized gastroenterology and earned Marshall and Warren the Nobel Prize in Physiology or Medicine in 2005. In this video, Nick and Joris highlight not only the scientific process behind the discovery but also the risks and innovation that make research in infectious diseases so exciting.
If you’re fascinated by microbiology, medical device development, and real-world medical breakthroughs, this story of discovery is one you won’t want to miss.
Groundbreaking Discoveries in Infectious Disease
For Startups or Founders developing a device that incorporates novel technology or is like nothing else, the FDA breakthrough medical device program may be the best regulatory option. Learn more.
Related Resources

In this Before the Build episode, Eric Olson and Paul Charlebois reflect on the value of patient-centered field research—and how firsthand observation can reframe design priorities and impact outcomes in profound ways.

Each summer, the laboratory diagnostics showcase hosted by the Association for Diagnostics & Laboratory Medicine (ADLM) draws industry leaders to Chicago.

Nigel and Nick explore how contrast agents in imaging support medical device trials and diagnostics. While bones appear clearly in standard X-rays, soft tissues like those in the nasal cavity often require contrast agents to become visible.

What does empathetic medical design really look like in practice? Eric and Paul discuss how emotional insight from field research can profoundly impact the design of medical devices